Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid

Background: Voriconazole is an antifungal drug used as one of the first-line treatments for invasive aspergillosis. This drug is extensively metabolized, predominantly via cytochrome P450 enzymes. An interaction between flucloxacillin and voriconazole, leading to subtherapeutic voriconazole concentr...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Daele, Ruth, Wauters, Joost, De Cock, Pieter, Buyle, Franky, Leys, John, Van Brantegem, Pieter, Gijsen, Matthias, Annaert, Pieter, Debaveye, Yves, Lagrou, Katrien, Peetermans, Willy E., Brüggemann, Roger J., Spriet, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469006/
https://www.ncbi.nlm.nih.gov/pubmed/34572694
http://dx.doi.org/10.3390/antibiotics10091112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469006/
https://www.ncbi.nlm.nih.gov/pubmed/34572694
http://dx.doi.org/10.3390/antibiotics10091112

Ejemplares similares